These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11361772)

  • 1. Final CESARE trial results show continued clinical and survival benefit.
    AIDS Patient Care STDS; 1997 Apr; 11(2):96. PubMed ID: 11361772
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial.
    Lancet; 1997 May; 349(9063):1413-21. PubMed ID: 9164314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
    Lancet; 1999 Jun; 353(9169):2014-25. PubMed ID: 10376616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy increases survival.
    Treat Rev; 1995 Nov; (no 20):2-3. PubMed ID: 11363019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AVANTI 1: randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus loviride in HIV-infected antiretroviral-naive patients. AVANTI Study Group.
    Gatell J; Lange J; Gartland M
    Antivir Ther; 1999; 4(2):79-86. PubMed ID: 10682152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee.
    Lancet; 1996 Aug; 348(9023):283-91. PubMed ID: 8709686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of combination therapy confirmed.
    Cheng B
    PI Perspect; 1995 Dec; (no 17):3-4. PubMed ID: 11363111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3TC: combination trial stopped early as clinical benefit shown.
    James JS
    AIDS Treat News; 1996 Aug; (no 252):5. PubMed ID: 11363752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on clinical trials of combination therapies for HIV infection.
    NIAID AIDS Agenda; 1995 Sep; ():8. PubMed ID: 11362803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AZT studies reinforce benefits of combination.
    AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTG 315 drug cocktail restores immune function.
    AIDS Patient Care STDS; 1997 Jun; 11(3):193. PubMed ID: 11361794
    [No Abstract]   [Full Text] [Related]  

  • 12. Research study of combination AIDS therapies underway.
    AIDS Patient Care STDS; 1996 Apr; 10(2):132. PubMed ID: 11361697
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiretroviral therapy. Current status and perspectives].
    Lüthy R
    Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223
    [No Abstract]   [Full Text] [Related]  

  • 14. Cure or control of HIV/AIDS?
    Collins DO; Sakamoto A
    Med Hypotheses; 1997 Jun; 48(6):489-90. PubMed ID: 9247891
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination treatment and single drugs: interview with Margaret Poscher, M.D. Interview by John S. James.
    Poscher M
    AIDS Treat News; 1995 Jul; (no 226):2-4 contd. PubMed ID: 11362613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Top AIDS researchers' strategy for antiretroviral treatment.
    AIDS Alert; 1996 Sep; 11(9):97-100. PubMed ID: 11363728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA Committee recommends clearance for HIVID combination therapy.
    AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361630
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crixivan reduces viral load.
    AIDS Patient Care STDS; 1996 Feb; 10(1):50. PubMed ID: 11361665
    [No Abstract]   [Full Text] [Related]  

  • 20. A closer look at 3TC. Interview by Mark Mascolini.
    Rubin M
    J Int Assoc Physicians AIDS Care; 1995 Jul; 1(6):21-5. PubMed ID: 11362724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.